| A20000127 | 丙酸氟替卡松气雾剂 | fluticasone propionate | Aerosol | Chemical Drugs | New Drug Application | 2000-10-25 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| JYSB1900152 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-07-17 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-08-31 | view |
| JYHB1000560 | 阿莫西林克拉维酸钾干混悬剂 | amoxicillin;potassium clavulanate | Suspension | Chemical Drugs | Supplementary Application | 2010-07-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd | Certificate Issued | 2011-03-24 | view |
| JYSB1900255 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-09-18 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-09-08 | view |
| JYHB1600510 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2016-05-10 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2017-03-29 | view |
| JXSS2100017 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-25 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | In Review | 2021-02-24 | view |
| JYSB1900148 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-07-17 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-06-10 | view |
| B20020076 | 硫酸阿巴卡韦片 | abacavir sulfate | Tablet | Chemical Drugs | Import Drug Application | 2002-07-15 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2002-12-02 | view |
| JYSB1900160 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-08-07 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2019-10-18 | view |
| JYHB1401055 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2014-07-30 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2015-02-03 | view |
| JYSB2000115 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2020-04-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-06-23 | view |
| JYSB1900080 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-04-15 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2019-09-29 | view |
| JZHR0900001 | 克拉维酸钾/二氧化硅 | Potassium Clavulanate;silicon dioxide | Active ingredient | Chemical Drugs | State Standards | 2009-06-26 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2010-08-16 | view |
| JYSB1900254 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-09-18 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-09-08 | view |
| JXSL1400048 | Belimumab | belimumab | Other | Biological Products | Import Drug Application | 2014-10-30 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd | Certificate Issued | 2017-05-19 | view |
| JXSL2000212 | 人轮状病毒减毒活疫苗 | | Diagnostic reagent | Biological Products(3.1) | Import Drug Application | 2020-12-03 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | In Review | 2020-12-03 | view |
| JYSB1900147 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-07-17 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-06-10 | view |
| AS20020007 | 吸附无细胞百日咳,白喉,破伤风和b型流感嗜血杆菌联合疫苗 | Diphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine | Other | Biological Products | New Drug Application | 2002-04-01 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2003-09-04 | view |
| JYSB1900164 | 双价人乳头瘤病毒吸附疫苗 | Human Papillomavirus (Types 16,18) Vaccine, Adsorbed | Injection | Biological Products | Supplementary Application | 2019-08-07 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2019-10-18 | view |
| CXLb20020005 | 沙美特罗替卡松吸入粉剂(原名：沙美特罗/丙酸氟替卡松吸入粉剂) | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs(4+5) | Supplementary Application | 2002-03-12 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2002-08-16 | view |
